Deep computational analysis details dysregulation of eukaryotic translation initiation complex eIF4F in human cancers

Abbas, 2016, The 7q11.23 microduplication syndrome: a clinical report with review of literature, J. Pediatr. Genet., 5, 129, 10.1055/s-0036-1584361 Aitken, 2012, A mechanistic overview of translation initiation in eukaryotes, Nat. Struct. Mol. Biol., 19, 568, 10.1038/nsmb.2303 Azar, 2013, Contribution of HIF-1alpha in 4E-BP1 gene expression, Mol. Cancer Res., 11, 54, 10.1158/1541-7786.MCR-12-0095 Badura, 2012, DNA damage and eIF4G1 in breast cancer cells reprogram translation for survival and DNA repair mRNAs, Proc. Natl. Acad. Sci. USA, 109, 18767, 10.1073/pnas.1203853109 Barretina, 2012, The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity, Nature, 483, 603, 10.1038/nature11003 Bhat, 2015, Targeting the translation machinery in cancer, Nat. Rev. Drug Discov., 14, 261, 10.1038/nrd4505 Braunstein, 2007, A hypoxia-controlled cap-dependent to cap-independent translation switch in breast cancer, Mol. Cell, 28, 501, 10.1016/j.molcel.2007.10.019 Buszczak, 2014, Cellular differences in protein synthesis regulate tissue homeostasis, Cell, 159, 242, 10.1016/j.cell.2014.09.016 Cancer Genome Atlas Research Network, 2013, The cancer genome atlas pan-cancer analysis project, Nat. Genet., 45, 1113, 10.1038/ng.2764 Dobrikov, 2018, Ribosomal RACK1: protein kinase C βII phosphorylates eukaryotic initiation factor 4G1 at S1093 to modulate cap-dependent and -independent translation initiation, Mol. Cell. Biol., 38, e00304 Dobrikov, 2014, Mitotic phosphorylation of eukaryotic initiation factor 4G1 (eIF4G1) at Ser1232 by Cdk1:cyclin B inhibits eIF4A helicase complex binding with RNA, Mol. Cell. Biol., 34, 439, 10.1128/MCB.01046-13 Duncan, 1987, Regulated phosphorylation and low abundance of HeLa cell initiation factor eIF-4F suggest a role in translational control. Heat shock effects on eIF-4F, J. Biol. Chem., 262, 380, 10.1016/S0021-9258(19)75938-9 Feoktistova, 2013, Human eIF4E promotes mRNA restructuring by stimulating eIF4A helicase activity, Proc. Natl. Acad. Sci. USA, 110, 13339, 10.1073/pnas.1303781110 Fukuchi-Shimogori, 1997, Malignant transformation by overproduction of translation initiation factor eIF4G, Cancer Res., 57, 5041 Galicia-Vázquez, 2012, A cellular response linking eIF4AI activity to eIF4AII transcription, RNA, 18, 1373, 10.1261/rna.033209.112 Gan, 1998, Functional characterization of the internal ribosome entry site of eIF4G mRNA, J. Biol. Chem., 273, 5006, 10.1074/jbc.273.9.5006 Gillette, 2020, Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma, Cell, 182, 200, 10.1016/j.cell.2020.06.013 Gingras, 1999, Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism, Genes Dev, 13, 1422, 10.1101/gad.13.11.1422 Goldman, 2020, Visualizing and interpreting cancer genomics data via the Xena platform, Nat. Biotechnol., 38, 675, 10.1038/s41587-020-0546-8 Gordan, 2007, HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation, Cancer Cell, 12, 108, 10.1016/j.ccr.2007.07.006 Graff, 2008, Targeting the eukaryotic translation initiation factor 4E for cancer therapy, Cancer Res, 68, 631, 10.1158/0008-5472.CAN-07-5635 Graff, 2009, eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival, Cancer Res, 69, 3866, 10.1158/0008-5472.CAN-08-3472 Grüner, 2016, The structures of eIF4E-eIF4G complexes reveal an extended interface to regulate translation initiation, Mol. Cell, 64, 467, 10.1016/j.molcel.2016.09.020 Haghighat, 1997, eIF4G dramatically enhances the binding of eIF4E to the mRNA 5′-cap structure, J. Biol. Chem., 272, 21677, 10.1074/jbc.272.35.21677 Hara, 1998, Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism, J. Biol. Chem., 273, 14484, 10.1074/jbc.273.23.14484 Ho, 2016, Systemic reprogramming of translation efficiencies on oxygen stimulus, Cell Rep, 14, 1293, 10.1016/j.celrep.2016.01.036 Hsieh, 2010, Targeting eukaryotic translation initiation factor 4E (eIF4E) in cancer, Clin. Cancer Res., 16, 4914, 10.1158/1078-0432.CCR-10-0433 Hu, 2012, MNK2 inhibits eIF4G activation through a pathway involving serine-arginine-rich protein kinase in skeletal muscle, Sci. Signal., 5, ra14, 10.1126/scisignal.2002466 Hundsdoerfer, 2005, Eukaryotic translation initiation factor 4GI and p97 promote cellular internal ribosome entry sequence-driven translation, Proc. Natl. Acad. Sci. USA, 102, 13421, 10.1073/pnas.0506536102 Hutter, 2018, The cancer genome Atlas: creating lasting value beyond its data, Cell, 173, 283, 10.1016/j.cell.2018.03.042 Igreja, 2014, 4E-BPs require non-canonical 4E-binding motifs and a lateral surface of eIF4E to repress translation, Nat. Commun., 5, 4790, 10.1038/ncomms5790 Imataka, 1997, Human eukaryotic translation initiation factor 4G (eIF4G) possesses two separate and independent binding sites for eIF4A, Mol. Cell. Biol., 17, 6940, 10.1128/MCB.17.12.6940 Jackson, 2010, The mechanism of eukaryotic translation initiation and principles of its regulation, Nat. Rev. Mol. Cell Biol., 11, 113, 10.1038/nrm2838 Jaiswal, 2018, Eukaryotic translation initiation factor 4 gamma 1 (eIF4G1) is upregulated during prostate cancer progression and modulates cell growth and metastasis, Sci. Rep., 8, 7459, 10.1038/s41598-018-25798-7 Jauch, 2006, Mitogen-activated protein kinases interacting kinases are autoinhibited by a reprogrammed activation segment, EMBO J, 25, 4020, 10.1038/sj.emboj.7601285 Johannes, 1998, Cap-independent polysomal association of natural mRNAs encoding c-myc, BiP, and eIF4G conferred by internal ribosome entry sites, RNA, 4, 1500, 10.1017/S1355838298981080 Jones, 1996, An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc, Mol. Cell. Biol., 16, 4754, 10.1128/MCB.16.9.4754 Kim, 2003, Heterogeneous nuclear ribonucleoprotein C modulates translation of c-myc mRNA in a cell cycle phase-dependent manner, Mol. Cell. Biol., 23, 708, 10.1128/MCB.23.2.708-720.2003 Knauf, 2001, Negative regulation of protein translation by mitogen-activated protein kinase-interacting kinases 1 and 2, Mol. Cell. Biol., 21, 5500, 10.1128/MCB.21.16.5500-5511.2001 Kolupaeva, 2003, Eukaryotic initiation factors 4G and 4A mediate conformational changes downstream of the initiation codon of the encephalomyocarditis virus internal ribosomal entry site, Mol. Cell. Biol., 23, 687, 10.1128/MCB.23.2.687-698.2003 Lee, 2016, eIF3d is an mRNA cap-binding protein that is required for specialized translation initiation, Nature, 536, 96, 10.1038/nature18954 Lin, 2008, c-Myc and eIF4F are components of a feedforward loop that links transcription and translation, Cancer Res, 68, 5326, 10.1158/0008-5472.CAN-07-5876 Liu, 2018, An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics, Cell, 173, 400, 10.1016/j.cell.2018.02.052 Liu, 2006, Hypoxia-induced energy stress regulates mRNA translation and cell growth, Mol. Cell, 21, 521, 10.1016/j.molcel.2006.01.010 Lomakin, 2000, Physical association of eukaryotic initiation factor 4G (eIF4G) with eIF4A strongly enhances binding of eIF4G to the internal ribosomal entry site of encephalomyocarditis virus and is required for internal initiation of translation, Mol. Cell. Biol., 20, 6019, 10.1128/MCB.20.16.6019-6029.2000 Marintchev, 2009, Topology and regulation of the human eIF4A/4G/4H helicase complex in translation initiation, Cell, 136, 447, 10.1016/j.cell.2009.01.014 Melé, 2015, Human genomics. The human transcriptome across tissues and individuals, Science, 348, 660, 10.1126/science.aaa0355 Mermel, 2011, GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers, Genome Biol, 12, R41, 10.1186/gb-2011-12-4-r41 Merrick, 2004, Cap-dependent and cap-independent translation in eukaryotic systems, Gene, 332, 1, 10.1016/j.gene.2004.02.051 Merrick, 2015, eIF4F: a retrospective, J. Biol. Chem., 290, 24091, 10.1074/jbc.R115.675280 Mertins, 2016, Proteogenomics connects somatic mutations to signalling in breast cancer, Nature, 534, 55, 10.1038/nature18003 Méthot, 1996, A region rich in aspartic acid, arginine, tyrosine, and glycine (DRYG) mediates eukaryotic initiation factor 4B (eIF4B) self-association and interaction with eIF3, Mol. Cell. Biol., 16, 5328, 10.1128/MCB.16.10.5328 Moore, 2009, Pre-mRNA processing reaches back to transcription and ahead to translation, Cell, 136, 688, 10.1016/j.cell.2009.02.001 Morgan, 1988, Fragile sites at 4q23 and 7q11.23 unique to bone marrow cells, Cancer Genet. Cytogenet., 31, 47, 10.1016/0165-4608(88)90010-6 Morino, 2000, Eukaryotic translation initiation factor 4E (eIF4E) binding site and the middle one-third of eIF4GI constitute the core domain for cap-dependent translation, and the C-terminal one-third functions as a modulatory region, Mol. Cell. Biol., 20, 468, 10.1128/MCB.20.2.468-477.2000 Nanbru, 1997, Alternative translation of the proto-oncogene c-myc by an internal ribosome entry site, J. Biol. Chem., 272, 32061, 10.1074/jbc.272.51.32061 Nusinow, 2020, Quantitative proteomics of the cancer cell line encyclopedia, Cell, 180, 387, 10.1016/j.cell.2019.12.023 Osborne, 2013, eIF4E3 acts as a tumor suppressor by utilizing an atypical mode of methyl-7-guanosine cap recognition, Proc. Natl. Acad. Sci. USA, 110, 3877, 10.1073/pnas.1216862110 Park, 2017, Keratinization of lung squamous cell carcinoma is associated with poor clinical outcome, Tuberc. Respir. Dis. (Seoul), 80, 179, 10.4046/trd.2017.80.2.179 Pelletier, 2019, The organizing principles of eukaryotic ribosome recruitment, Annu. Rev. Biochem., 88, 307, 10.1146/annurev-biochem-013118-111042 Pyronnet, 2001, Suppression of cap-dependent translation in mitosis, Genes Dev, 15, 2083, 10.1101/gad.889201 Rogers, 2001, Modulation of the helicase activity of eIF4A by eIF4B, eIF4H, and eIF4F, J. Biol. Chem., 276, 30914, 10.1074/jbc.M100157200 Rosenwald, 1999, Upregulation of protein synthesis initiation factor eIF-4E is an early event during colon carcinogenesis, Oncogene, 18, 2507, 10.1038/sj.onc.1202563 Ruggero, 2013, Translational control in cancer etiology, Cold Spring Harb. Perspect. Biol., 5, a012336, 10.1101/cshperspect.a012336 Ruggero, 2004, The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis, Nat. Med., 10, 484, 10.1038/nm1042 Rutkovsky, 2019, Eukaryotic initiation factor 4E-binding protein as an oncogene in breast cancer, BMC Cancer, 19, 491, 10.1186/s12885-019-5667-4 Saxton, 2017, MTOR signaling in growth, metabolism, and disease, Cell, 168, 960, 10.1016/j.cell.2017.02.004 Schütz, 2010, Comparative structural analysis of human DEAD-box RNA helicases, PLoS One, 5, e12791, 10.1371/journal.pone.0012791 Schwanhäusser, 2011, Global quantification of mammalian gene expression control, Nature, 473, 337, 10.1038/nature10098 Sekiyama, 2015, Molecular mechanism of the dual activity of 4EGI-1: dissociating eIF4G from eIF4E but stabilizing the binding of unphosphorylated 4E-BP1, Proc. Natl. Acad. Sci. USA, 112, E4036, 10.1073/pnas.1512118112 Shahbazian, 2006, The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity, EMBO J, 25, 2781, 10.1038/sj.emboj.7601166 Sorrells, 1998, Detection of eIF4E gene amplification in breast cancer by competitive PCR, Ann. Surg. Oncol., 5, 232, 10.1007/BF02303778 Sorrells, 1999, Competitive PCR to detect eIF4E gene amplification in head and neck cancer, Head Neck, 21, 60, 10.1002/(SICI)1097-0347(199901)21:1<60::AID-HED8>3.0.CO;2-J Spriggs, 2010, Translational regulation of gene expression during conditions of cell stress, Mol. Cell, 40, 228, 10.1016/j.molcel.2010.09.028 Stoneley, 2000, c-Myc protein synthesis is initiated from the internal ribosome entry segment during apoptosis, Mol. Cell. Biol., 20, 1162, 10.1128/MCB.20.4.1162-1169.2000 Subkhankulova, 2001, Internal ribosome entry segment-mediated initiation of c-Myc protein synthesis following genotoxic stress, Biochem. J., 359, 183, 10.1042/bj3590183 Sun, 2019, Mitosis-related phosphorylation of the eukaryotic translation suppressor 4E-BP1 and its interaction with eukaryotic translation initiation factor 4E (eIF4E), J. Biol. Chem., 294, 11840, 10.1074/jbc.RA119.008512 Svitkin, 2005, Eukaryotic translation initiation factor 4E availability controls the switch between cap-dependent and internal ribosomal entry site-mediated translation, Mol. Cell. Biol., 25, 10556, 10.1128/MCB.25.23.10556-10565.2005 Tabak, 2019, The Tangent copy-number inference pipeline for cancer genome analyses, bioRxiv Timp, 2020, Beyond mass spectrometry, the next step in proteomics, Sci. Adv., 6, eaax8978, 10.1126/sciadv.aax8978 Trop-Steinberg, 2018, Is Myc an important biomarker? Myc expression in immune disorders and cancer, Am. J. Med. Sci., 355, 67, 10.1016/j.amjms.2017.06.007 van Gorp, 2009, AGC kinases regulate phosphorylation and activation of eukaryotic translation initiation factor 4B, Oncogene, 28, 95, 10.1038/onc.2008.367 Vivian, 2017, Toil enables reproducible, open source, big biomedical data analyses, Nat. Biotechnol., 35, 314, 10.1038/nbt.3772 Walsh, 2011, Viral subversion of the host protein synthesis machinery, Nat. Rev. Microbiol., 9, 860, 10.1038/nrmicro2655 Wangpaichitr, 2008, Intrinsically lower AKT, mammalian target of rapamycin, and hypoxia-inducible factor activity correlates with increased sensitivity to 2-deoxy-D-glucose under hypoxia in lung cancer cell lines, Mol. Cancer Ther., 7, 1506, 10.1158/1535-7163.MCT-07-2334 Waskiewicz, 1999, Phosphorylation of the cap-binding protein eukaryotic translation initiation factor 4E by protein kinase Mnk1 in vivo, Mol. Cell. Biol., 19, 1871, 10.1128/MCB.19.3.1871 Wu, 2019, SREBP1-dependent de novo fatty acid synthesis gene expression is elevated in malignant melanoma and represents a cellular survival trait, Sci. Rep., 9, 10369, 10.1038/s41598-019-46594-x Yi, 2013, Hypoxia-inducible factor-1alpha (HIF-1alpha) promotes cap-dependent translation of selective mRNAs through up-regulating initiation factor eIF4E1 in breast cancer cells under hypoxia conditions, J. Biol. Chem., 288, 18732, 10.1074/jbc.M113.471466